Specified Drug Use-results Survey of Betanis Tablets in OAB Patients With Coexisting Glaucoma
Phase of Trial: Phase IV
Latest Information Update: 07 Feb 2018
Price : $35 *
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Adverse reactions
- Sponsors Astellas Pharma
- 01 Feb 2018 Status changed from recruiting to completed.
- 08 Jan 2016 Planned End Date changed from 1 Jan 2015 to 1 Jan 2018 as reported by ClinicalTrials.gov.
- 08 Jan 2016 Planned primary completion date changed from 1 Jan 2015 to 1 Jan 2018 as reported by ClinicalTrials.gov.